Pharmaceuticals News and Research

RSS

Solvanix set up to commercialise novel antibody-stabilisation technology

The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies.

17 Jan 2015

Study: Stem cells derived from human female amnion have anti-inflammatory effects

Stem cells derived from human amnion have for some time been considered promising for cell therapies because of their ease of access, ability to differentiate, and absence of ethical issues.

17 Jan 2015

Fast HPLC screening methods used to detect steroids

As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.

16 Jan 2015

MRIGlobal awarded $54 million NIH contract to provide support for drug development

MRIGlobal today announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.

15 Jan 2015

China Jo-Jo Drugstores opens eight new retail pharmacies in Hangzhou

China Jo-Jo Drugstores, Inc., a leading China-based retail and wholesale distributor of pharmaceutical and health care products through its own online and retail pharmacies, announced today that it opened eight new retail pharmacies in Hangzhou on January 10, 2015, a company record for same-day store openings.

15 Jan 2015

CTI Life Sciences announces closing of second venture capital fund

CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.

15 Jan 2015

YODA Project announces availability of clinical trial data for medical devices

The Yale University Open Data Access (YODA) Project is announcing the first-ever broad availability of clinical trial data for medical devices and diagnostics by a company. This historic expansion of data sharing is made possible through collaboration with Johnson & Johnson.

15 Jan 2015

Crown's first European symposium to focus on use of Translational Platforms in oncology drug discovery

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced its first European symposium, detailing the use of Translational Platforms including Patient-Derived Xenograft (PDX) models in oncology drug discovery and development. The conference will be held on Wednesday 11th February, at the headquarters of One Nucleus in Cambridge, UK and will welcome experts from renowned pharmaceutical companies and prominent academics working in oncology.

15 Jan 2015

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.

14 Jan 2015

PharmaMar to begin PM1183 Phase III trial in combination with doxorubicin in SCLC

Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in SCLC, given the activity observed in an interim analysis of an ongoing Phase Ib trial. The results of this study will be presented at a prominent international cancer meeting this year, which will be soon announced.

14 Jan 2015

QDREC software may help find effective treatment for schistosomiasis

For decades, scientists around the world have worked to develop a treatment for schistosomiasis, a debilitating water-born parasite that affects more than 200 million people worldwide. To aid this research, Rahul Singh, professor of computer science at San Francisco State University, has developed software that solves the key challenge of quantitatively assessing the impact of a drug on the parasite.

14 Jan 2015

Duke researchers grow contracting human skeletal muscle in lab

In a laboratory first, Duke researchers have grown human skeletal muscle that contracts and responds just like native tissue to external stimuli such as electrical pulses, biochemical signals and pharmaceuticals.

13 Jan 2015

Interactive virtual human body: an interview with Frank Sculli, CEO, BioDigital

The BioDigital Human is an interactive, virtual model of the human body that addresses huge deficiencies in health education and communication. From diagnosis to drugs to devices, the human provides an engaging way to really understand complex health information.

13 Jan 2015

Using MDRS to accelerate deformulation: a new whitepaper from Malvern Instruments

A new whitepaper from Malvern Panalytical on Oral Solid Dose (OSD) deformulation demonstrates how the analytical technique of Morphologically Directed Raman Spectroscopy (MDRS) can be used to accelerate the development of generic products to a successful conclusion.

From Malvern Panalytical 13 Jan 2015

eAgile releases new UHF EPC compliant MicroWing inlay

eAgile Inc., a global leader in radio frequency identification (RFID) technologies, announced today the release of their new UHF EPC compliant MicroWing inlay. The MicroWing is the size of a paper clip which makes it the smallest RFID inlay available on the market to achieve a greater than 2 meter read range.

13 Jan 2015

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

Digital has excited the industry, it has hinted at a brighter future, a potential competitive advantage and most importantly a better purpose, however like many others, it has not been the revolution it might have been.

13 Jan 2015

Beckman Coulter Life Sciences expands range of Avanti High Performance centrifuges

Beckman Coulter Life Sciences continues to expand its range of Avanti High Performance centrifuges with the launch of the Avanti JXN-30.

From Beckman Coulter Life Sciences - Centrifugation 13 Jan 2015

MGB Biopharma provides update on business performance for 2014

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, provides an update on its business performance for 2014. MGB Biopharma is developing a pipeline of novel antimicrobials that puts it at the forefront of addressing the major global problem of antimicrobial resistance.

12 Jan 2015

Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Altos Therapeutics, LLC announced today that the Mexican Institute of Industrial Property has issued Patent Number 323020 titled, "D2 Antagonists, Methods of Synthesis and Methods of Use". The patent broadly and specifically covers the company's dopamine D2/D3 drug candidates, their pharmaceutical compositions, and their use to treat a number of important gastrointestinal conditions in humans, such as gastroparesis.

12 Jan 2015

Virginia Tech scientists plan to design virus to switch wound-healing drug into cancer fighter

At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer.

12 Jan 2015

Pharmaceuticals News and Research

Solvanix set up to commercialise novel antibody-stabilisation technology

Study: Stem cells derived from human female amnion have anti-inflammatory effects

Fast HPLC screening methods used to detect steroids

MRIGlobal awarded $54 million NIH contract to provide support for drug development

China Jo-Jo Drugstores opens eight new retail pharmacies in Hangzhou

CTI Life Sciences announces closing of second venture capital fund

YODA Project announces availability of clinical trial data for medical devices

Crown's first European symposium to focus on use of Translational Platforms in oncology drug discovery

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

PharmaMar to begin PM1183 Phase III trial in combination with doxorubicin in SCLC

QDREC software may help find effective treatment for schistosomiasis

Duke researchers grow contracting human skeletal muscle in lab

Interactive virtual human body: an interview with Frank Sculli, CEO, BioDigital

Using MDRS to accelerate deformulation: a new whitepaper from Malvern Instruments

eAgile releases new UHF EPC compliant MicroWing inlay

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

Beckman Coulter Life Sciences expands range of Avanti High Performance centrifuges

MGB Biopharma provides update on business performance for 2014

Altos Therapeutics announces issuance of Mexican patent covering dopamine D2/D3 drug candidates

Virginia Tech scientists plan to design virus to switch wound-healing drug into cancer fighter

Event guide: 3rd EHS for Biopharma Summit eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence